{
    "id": 29554,
    "fullName": "MMP14 positive",
    "impact": "unknown",
    "proteinEffect": "unknown",
    "geneVariantDescriptions": [
        {
            "description": "MMP14 positive indicates the presence of the MMP14 gene, mRNA, and/or protein.",
            "references": [
                {
                    "id": 275,
                    "pubMedId": null,
                    "title": "External Reference Not Available (N/A)",
                    "url": "https://ckb.jax.org/about/glossaryOfTerms"
                }
            ]
        }
    ],
    "type": "non-specific",
    "gene": {
        "id": 4323,
        "geneSymbol": "MMP14",
        "terms": [
            "MMP14",
            "MMP-14",
            "MMP-X1",
            "MT-MMP",
            "MT-MMP 1",
            "MT1-MMP",
            "MT1MMP",
            "MTMMP1",
            "WNCHRS"
        ]
    },
    "variant": "positive",
    "createDate": "03/14/2019",
    "updateDate": "03/14/2019",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 16366,
            "approvalStatus": "Preclinical - Pdx",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, BT1718 demonstrated anti-tumor activity dependent on Mmp14 (MT-MMP1) expression level in a panel of cell line and patient-derived xenograft (PDX) models of solid tumors including lung, breast, colorectal, stomach, head and neck cancer, and multiple myeloma, with partial or complete tumor regression in Mmp14-moderate or high models, and limited or no effect in Mmp14-low models (Mol Cancer Ther 2018;17(1 Suppl):Abstract nr B135).",
            "molecularProfile": {
                "id": 31612,
                "profileName": "MMP14 positive"
            },
            "therapy": {
                "id": 8008,
                "therapyName": "BT1718",
                "synonyms": null
            },
            "indication": {
                "id": 10000003,
                "name": "Advanced Solid Tumor",
                "source": "JAX"
            },
            "responseType": "predicted - sensitive",
            "references": [
                {
                    "id": 14465,
                    "pubMedId": null,
                    "title": "The mechanism of action of BT1718, a novel small-molecule drug conjugate for the treatment of solid tumors expressing MT1-MMP",
                    "url": "http://mct.aacrjournals.org/content/17/1_Supplement/B135"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 31612,
            "profileName": "MMP14 positive",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}